Pancreatic cancer mRNA vaccine shows lasting results in an early trial: Scientists caution that more research is needed, but nearly all of the patients who responded to the personalized vaccine are still alive six years later19. April 2026
News Houston Methodist to Deploy Midstream Health’s Agentic AI Financial Action Platform Across EnterpriseHealthradar8. April 2026 What You Should Know The Deployment: Midstream Health has announced a strategic collaboration with Houston Methodist to deploy its AI-powered…
